Skip to main content
Top
Published in: Cancer and Metastasis Reviews 3/2019

01-09-2019 | Prostate Cancer

Biography—Judith Clements

Published in: Cancer and Metastasis Reviews | Issue 3/2019

Login to get access

Excerpt

Judith Clements obtained her PhD from Monash University, Melbourne, Australia, in 1989. She moved to Queensland University of Technology (QUT) in Brisbane, Australia, in 1996 where she initiated and led the Cancer Program within the School of Biomedical Sciences and Institute of Health and Biomedical Innovation (IHBI) from 1997 to 2014. During that time, the program grew from a small group of 6–8 researchers to now > 100 staff and postgraduate students. She was co-founder and former Scientific Director, until 2017, of the Australian Prostate Cancer Research Centre-Queensland, within IHBI, QUT and which is located at the Translational Research Institute, Brisbane. She was continuously funded as a federal government funded National Health & Medical Research Council (NHMRC) Principal Research Fellow for 16 years from 2000 to 2016 and was actively involved in NHMRC peer review in that time. She was awarded the Queensland Women in Technology Biotech Outstanding Achievement Award for 2012, and the prestigious title of Distinguished Professor, the first woman in QUT’s history, in 2013 and Emeritus Professor in 2018. She became a fellow of the Australian Academy of Health & Medical Sciences in 2017. …
Metadata
Title
Biography—Judith Clements
Publication date
01-09-2019
Publisher
Springer US
Published in
Cancer and Metastasis Reviews / Issue 3/2019
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI
https://doi.org/10.1007/s10555-019-09809-1

Other articles of this Issue 3/2019

Cancer and Metastasis Reviews 3/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine